These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19808302)

  • 1. Clinical use of phosphodiesterase-5 inhibitors in chronic heart failure.
    Guazzi M
    Circ Heart Fail; 2008 Nov; 1(4):272-80. PubMed ID: 19808302
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease.
    Kapur V; Chien CV; Fuess JE; Schwarz ER
    Rev Cardiovasc Med; 2008; 9(3):187-95. PubMed ID: 18953278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New inotropic drugs for treatment of congestive heart failure.
    Schwertz DW; Piano MR
    Cardiovasc Nurs; 1990; 26(2):7-12; discussion 12. PubMed ID: 1969769
    [No Abstract]   [Full Text] [Related]  

  • 5. Phosphodiesterase inhibitors. Do the risks outweight the benefits?
    Andrews R; Cowley AJ
    Drug Saf; 1993 Dec; 9(6):404-9. PubMed ID: 8129862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications.
    Kumar P; Francis GS; Tang WH
    Nat Rev Cardiol; 2009 May; 6(5):349-55. PubMed ID: 19377497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative administration of PDE-5 Inhibitors.
    Edwards AF; Roy RC
    J Clin Anesth; 2009 Mar; 21(2):149; author reply 149-50. PubMed ID: 19329023
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failure.
    Van Tassell BW; Radwanski P; Movsesian M; Munger MA
    Pharmacotherapy; 2008 Dec; 28(12):1523-30. PubMed ID: 19025433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase 5 inhibitors: are they cardioprotective?
    Reffelmann T; Kloner RA
    Cardiovasc Res; 2009 Jul; 83(2):204-12. PubMed ID: 19474180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasodilators in heart failure. Basis for their use].
    Mesquita ET; Mady C
    Arq Bras Cardiol; 1994 Dec; 63(6):531-6. PubMed ID: 7605242
    [No Abstract]   [Full Text] [Related]  

  • 11. Phosphodiesterase type 5 inhibition: a support of the left ventricular assist device bridge to transplant.
    Semigran MJ
    Circ Heart Fail; 2008 Nov; 1(4):211-2. PubMed ID: 19808293
    [No Abstract]   [Full Text] [Related]  

  • 12. Tadalafil (Cialis) once a day for erectile dysfunction.
    Med Lett Drugs Ther; 2008 Apr; 50(1283):27-8. PubMed ID: 18391900
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary vasodilation in acute and chronic heart failure: empiricism and evidence.
    Guglin M
    Curr Heart Fail Rep; 2011 Sep; 8(3):219-25. PubMed ID: 21556702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase type 5 inhibitors improve male lower urinary tract symptoms.
    Giuliano F
    Eur Urol; 2008 Jun; 53(6):1121-3; discussion 1123-4. PubMed ID: 18329786
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current role of non-digitalis inotropic agents in acute and chronic treatment of heart failure].
    Dei Cas L; Nodari S; Raddino R; Metra M; Pelà G; Nardi M
    Cardiologia; 1994 Mar; 39(3):209-15. PubMed ID: 8039201
    [No Abstract]   [Full Text] [Related]  

  • 16. [5-phosphodiesterase inhibitors and cardiovascular risk].
    Tostain J
    Prog Urol; 2008 Dec; 18(13):1091-2. PubMed ID: 19041817
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pulmonary hypertension and pulmonary circulation in congenital heart disease].
    Schulze-Neick I; Kaemmerer H
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S170-2. PubMed ID: 19718608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating heart failure with sildenafil.
    Blum A
    Congest Heart Fail; 2009; 15(4):181-5. PubMed ID: 19627292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of ramipril in treating patients with chronic heart failure].
    Sinitsina II; Orlov VA; Zakharova GIu; Giliarevskiĭ SR; Ivasenko LA
    Ter Arkh; 1995; 67(5):75-7. PubMed ID: 7638788
    [No Abstract]   [Full Text] [Related]  

  • 20. [Update: Current clinical developments in pulmonary hypertension].
    Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.